Zelira Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 23 shareholders own 52.15% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10%	Malik Majeed	1,134,644	€436.2k	0%	no data
4.02%	Quincy Street Capital Llc	456,622	€175.5k	0%	no data
3.78%	Osagie Imasogie	428,883	€164.9k	0%	no data
3.46%	Sharri Rochlin	393,168	€151.1k	0%	no data
3.46%	Zoltan Kerekes	393,168	€151.1k	0%	no data
3.38%	Jason Peterson	383,725	€147.5k	0%	no data
3.37%	Lisa Gray	381,988	€146.8k	0%	no data
2.93%	Mera I LLC	332,479	€127.8k	0%	no data
2.75%	Muller Ct Pty Ltd	312,126	€120.0k	164%	no data
2.71%	Torsten Geers	307,454	€118.2k	0%	no data
2.67%	Steve Shapiro	302,571	€116.3k	0%	no data
2.22%	Mara Gordon	252,242	€97.0k	0%	no data
1.29%	Chanda Macias	146,479	€56.3k	0%	no data
1.18%	Mera II LLC	133,372	€51.3k	0%	no data
1.16%	Oludare Odumosu	131,766	€50.7k	0%	no data
0.76%	Geers Egag LLC	85,715	€32.9k	0%	no data
0.67%	Saul Shorr	75,643	€29.1k	0%	no data
0.67%	Margaret Shorr	75,642	€29.1k	0%	no data
0.46%	Shannon Hexter	51,695	€19.9k	0%	no data
0.46%	Daniel Hexter	51,695	€19.9k	0%	no data
0.34%	Connie Katz	39,032	€15.0k	0%	no data
0.34%	Samuel Katz	39,032	€15.0k	0%	no data
0.069%	Timothy Slate	7,881	€3.0k	0%	no data